The Financial Impossibilities Of Making Antibiotics: Why Drugmakers Are Going Bust Even In Era Of Superbugs

Doctors are prescribing the drugs sparingly and patients only need to take them a week or two at a time. In a world where pricey million-dollar cancer drugs are king, drugmakers producing modest antibiotics are crashing just when the country needs them the most. In other pharmaceutical news: pay-to-delay deals, blockbuster treatments and a failed promise.

from Kaiser Health News https://ift.tt/2Fp8sUH